Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study

LA Pearce, JE Min, M Piske, H Zhou, F Homayra… - Bmj, 2020 - bmj.com
Objective To compare the risk of mortality among people with opioid use disorder on and off
opioid agonist treatment (OAT) in a setting with a high prevalence of illicitly manufactured …

Endogenous opiates and behavior: 2019

RJ Bodnar - Peptides, 2021 - Elsevier
This paper is the forty-second consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Protracted renal clearance of fentanyl in persons with opioid use disorder

AS Huhn, JG Hobelmann, GA Oyler… - Drug and alcohol …, 2020 - Elsevier
Introduction The illicit opioid supply in the US is increasingly adulterated with fentanyl. As
such, persons with opioid use disorder (OUD) may be regularly exposed to fentanyl …

Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone

D Antoine, AS Huhn, EC Strain, G Turner… - … American journal on …, 2021 - Wiley Online Library
Background and Objectives Individuals exposed to fentanyl are at risk of precipitated
withdrawal using typical buprenorphine/naloxone induction procedures. Methods This case …

Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated

NB Varshneya, SH Hassanien, MC Holt… - Biochemical …, 2022 - Elsevier
Opioid-related fatalities involving synthetic opioids have reached unprecedented levels. This
study evaluated the respiratory depressant effects of seven fentanyl analogs that have either …

Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression

NB Varshneya, SH Hassanien, MC Holt… - Pharmacology …, 2023 - Elsevier
Opioid overdoses, particularly those involving fentanyl-related substances (FRS), present a
significant public health challenge in the United States. This structure-activity relationship …

Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic

KE Dunn, RK Brooner, KB Stoller - Journal of Substance Abuse Treatment, 2021 - Elsevier
Introduction Covid-19 confers substantial risk for the> 400,000 patients who receive
methadone for the treatment of opioid use disorder (OUD) and methods for safely …

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

CM Laffont, E Ngaimisi, M Gopalakrishnan… - Frontiers in …, 2022 - frontiersin.org
The severity of the ongoing opioid crisis, recently exacerbated by the COVID-19 pandemic,
emphasizes the importance for individuals suffering from opioid use disorder (OUD) to have …

[PDF][PDF] Fentanyl: Clinical Applications and Pharmacological Considerations

I Karunarathna - Uva Clinical Lab. Retrieved from Fentanyl …, 2024 - researchgate.net
With its remarkable analgesic potency, often 50 to 100 times greater than morphine, fentanyl
presents a valuable tool in addressing acute and chronic pain, as well as in providing …

Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: a placebo-controlled crossover study in healthy volunteers …

LM Moss, MH Algera, R Dobbins, F Gray, S Strafford… - PLoS …, 2022 - journals.plos.org
Background Opioid-induced respiratory depression driven by ligand binding to mu-opioid
receptors is a leading cause of opioid-related fatalities. Buprenorphine, a partial agonist …